FARE Clinical Network
Changing the Face of Food Allergy Care
As the leading advocacy organization working on behalf of the 32 million Americans with food allergies and the largest private funder of food allergy research, FARE is committed to advancing life-changing and life-saving research that will improve the lives of individuals managing food allergies.
Created by FARE in 2015 with an initial investment of more than $2 million, the FARE Clinical Network is a bold initiative that aims to accelerate the development of drugs for patients with food allergies as well as improve the quality of care for this serious illness. The FARE Clinical Network, which now comprises more than thirty centers of excellence across the country, brings members together for a common goal of ensuring that patients with food allergies have access to state-of-the-art diagnosis, care, research and clinical trials.
The FARE Clinical Network is a powerful driver of collaboration to advance the field of food allergy. Under FARE's leadership and coordination, the centers of excellence selected to participate in this nationwide network:
- develop best practices for the care of patients with food allergies
- serve as sites for clinical trials for the development of new therapeutics
- contribute to the development of the FARE Patient Registry and food allergy biorepositories
The current FARE Clinical Network model will be restructured towards one that enables expansion of the number of sites with a focus on the strengths of each participating site. The new FCN model will include three different levels that sites can apply for, as well as a Communication and Coordination Center, a Data Center, and a Biobank and Biomarker Discovery Center.
What to Read Next
Patients and other key stakeholders partnering to develop a patient-centered food allergy research program informed by real-world experiences.